Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 10 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Mirum Pharmaceuticals, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 214
- +2 vs. Q1 2025
- Shares held
- 55.4M
- +1.30M (+2.4%) vs. Q1 2025
- Total value
- $2.82B
- +$377.6M (+15.5%) vs. Q1 2025
- New holders
- 35
- 76 more added
- Sold out
- 33
- 80 more reduced
2 institutions that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIRM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 326 | $8.36B |
| Q1 2026 | 311 | $6.29B |
| Q4 2025 | 284 | $4.82B |
| Q3 2025 | 272 | $4.20B |
| Q2 2025 | 214 | $2.82B |
| Q1 2025 | 214 | $2.44B |
| Q4 2024 | 205 | $2.19B |
| Q3 2024 | 178 | $2.08B |
| Q2 2024 | 161 | $1.83B |
| Q1 2024 | 172 | $1.34B |
| Q4 2023 | 187 | $1.48B |
| Q3 2023 | 159 | $1.55B |
| Q2 2023 | 146 | $955.6M |
| Q1 2023 | 117 | $832.9M |
| Q4 2022 | 104 | $650.2M |
| Q3 2022 | 112 | $709.1M |
| Q2 2022 | 110 | $569.4M |
| Q1 2022 | 99 | $590.4M |
| Q4 2021 | 86 | $395.7M |
| Q3 2021 | 73 | $465.0M |
| Q2 2021 | 67 | $404.6M |
| Q1 2021 | 61 | $463.3M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Mirum Pharmaceuticals, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Capital Holdings Plc | 975,000 | $49.6M | 0.26% | −200,000−17.0% | Reduced |
| Clearbridge Investments, LLC | 1,027,527 | $52.3M | 0.04% | +49,460+5.1% | Added |
| Geode Capital Management, LLC | 1,029,616 | $52.4M | 0.00% | +65,951+6.8% | Added |
| Tang Capital Management LLC | 1,236,027 | $62.9M | 3.18% | −1,080−0.1% | Reduced |
| State Street Corp | 1,375,628 | $70.0M | 0.00% | −118,938−8.0% | Reduced |
| Citadel Advisors LLC | 1,406,352 | $71.6M | 0.06% | −39,643−2.7% | Reduced |
| Price T Rowe Associates Inc | 1,417,215 | $72.1M | 0.01% | +2,078+0.1% | Added |
| Novo Holdings A/S | 1,500,055 | $76.3M | 5.39% | +550.0% | Added |
| Vanguard Group Inc | 2,564,869 | $130.5M | 0.00% | +24,808+1.0% | Added |
| Eventide Asset Management, LLC | 2,637,485 | $134.2M | 2.35% | +110,485+4.4% | Added |
| BVF Inc | 2,761,333 | $140.5M | 5.02% | −35,180−1.3% | Reduced |
| BlackRock, Inc. | 3,577,091 | $182.0M | 0.00% | +237,534+7.1% | Added |
| Janus Henderson Group PLC | 5,236,277 | $266.5M | 0.13% | +470,168+9.9% | Added |
| Frazier Life Sciences Management, L.P. | 6,795,121 | $345.8M | 13.83% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 0 | $0 | 0.00% | −146,765−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −72,678−100.0% | Sold out |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −38,386−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −37,969−100.0% | Sold out |
| Semanteon Capital Management, LP | 0 | $0 | 0.00% | −31,478−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −26,816−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −25,944−100.0% | Sold out |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −23,500−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −19,458−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −18,425−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −15,691−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −8,942−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −8,786−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −6,500−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −6,043−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −5,260−100.0% | Sold out |
| Caxton Associates LLP | 0 | $0 | 0.00% | −4,808−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −4,464−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −3,283−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −1,250−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −694−100.0% | Sold out |
| BI Asset Management Fondsmaeglerselskab A/S | 0 | $0 | 0.00% | −727−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −296−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −263−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −235−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −117−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −99−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Stephens Consulting, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Kodai Capital Management LP | – | – | – | – | Not filed |
| Lindbrook Capital, LLC | – | – | – | – | Not filed |